Clinical Trial

Dose-Finding Study of HUC1-394 in Participants With Dry Eye Disease

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Clinical trial aims to determine the optimal dosing regimen by evaluating the efficacy and safety of HUC1-394 across different dosing frequencies in patients with moderate to severe dry eye disease.
Protocol Amendment History 1 change
critical Primary endpoint(s) modified 2026-07-02
Trial Details
NCT Number NCT07656688
Lead Sponsor Huons Co., Ltd.
Conditions Dry Eye Disease (DED)
Enrollment 150 participants
Start Date 2026-07
Primary Completion 2027-06 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2026-07-01